Comment Period Extended to 3/23/2015 for Notice of Proposed Rulemaking (NPRM) for FDAAA 801 and NIH Draft Reporting Policy for NIH-Funded Trials

URACYST® For the Treatment of GAG Deficient Interstitial Cystitis

This study has been completed.
Sponsor:
Collaborator:
Stellar Pharmaceuticals
Information provided by:
Queen's University
ClinicalTrials.gov Identifier:
NCT00150488
First received: September 6, 2005
Last updated: September 17, 2008
Last verified: September 2008
No Study Results Posted on ClinicalTrials.gov for this Study
  Study Status: This study has been completed.
  Study Completion Date: February 2008
  Primary Completion Date: January 2008 (Final data collection date for primary outcome measure)